123 related articles for article (PubMed ID: 22113177)
1. Immunolocalization of nestin, mesothelin and epithelial membrane antigen (EMA) in developing and adult serous membranes and mesotheliomas.
Petricevic J; Punda H; Brakus SM; Vukojevic K; Govorko DK; Alfirevic D; Kvesic A; Saraga-Babic M
Acta Histochem; 2012 Sep; 114(5):469-79. PubMed ID: 22113177
[TBL] [Abstract][Full Text] [Related]
2. Expression of nestin, mesothelin and epithelial membrane antigen (EMA) in developing and adult human meninges and meningiomas.
Petricevic J; Forempoher G; Ostojic L; Mardesic-Brakus S; Andjelinovic S; Vukojevic K; Saraga-Babic M
Acta Histochem; 2011 Nov; 113(7):703-11. PubMed ID: 20943257
[TBL] [Abstract][Full Text] [Related]
3. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
Su XY; Li GD; Liu WP; Xie B; Jiang YH
Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
[TBL] [Abstract][Full Text] [Related]
4. Value of mesothelin immunostaining in the diagnosis of mesothelioma.
Ordóñez NG
Mod Pathol; 2003 Mar; 16(3):192-7. PubMed ID: 12640097
[TBL] [Abstract][Full Text] [Related]
5. The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2.
Attanoos RL; Griffin A; Gibbs AR
Histopathology; 2003 Sep; 43(3):231-8. PubMed ID: 12940775
[TBL] [Abstract][Full Text] [Related]
6. Expression of epithelial membrane antigen on malignant mesothelioma cells. An immunocytochemical and immunoelectron microscopic study.
van der Kwast TH; Versnel MA; Delahaye M; de Jong A; Zondervan PE; Hoogsteden H
Acta Cytol; 1988; 32(2):169-74. PubMed ID: 3348058
[TBL] [Abstract][Full Text] [Related]
7. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture.
LaRocca PJ; Rheinwald JG
Cancer Res; 1984 Jul; 44(7):2991-9. PubMed ID: 6202404
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor receptor immunoreactivity in mesothelioma and nonneoplastic mesothelial cells in serous effusions.
Ascoli V; Scalzo CC; Facciolo F; Nardi F
Acta Cytol; 1995; 39(4):613-22. PubMed ID: 7543232
[TBL] [Abstract][Full Text] [Related]
10. Significance of epithelial membrane antigen in the work-up of problematic serous effusions.
Singh HK; Silverman JF; Berns L; Haddad MG; Park HK
Diagn Cytopathol; 1995 Jul; 13(1):3-7. PubMed ID: 7587872
[TBL] [Abstract][Full Text] [Related]
11. Serosal membranes (pleura, pericardium, peritoneum). Normal structure, development and experimental pathology.
Michailova KN; Usunoff KG
Adv Anat Embryol Cell Biol; 2006; 183():i-vii, 1-144, back cover. PubMed ID: 16570866
[TBL] [Abstract][Full Text] [Related]
12. Spatiotemporal expression pattern of neuroepithelial stem cell marker nestin suggests a role in dermal homeostasis, neovasculogenesis, and tumor stroma development: a study on embryonic and adult human skin.
Sellheyer K; Krahl D
J Am Acad Dermatol; 2010 Jul; 63(1):93-113. PubMed ID: 19864043
[TBL] [Abstract][Full Text] [Related]
13. The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: a comparative study.
Saad RS; Cho P; Liu YL; Silverman JF
Diagn Cytopathol; 2005 Mar; 32(3):156-9. PubMed ID: 15690334
[TBL] [Abstract][Full Text] [Related]
14. Practical utility of insulin-like growth factor II mRNA-binding protein 3, glucose transporter 1, and epithelial membrane antigen for distinguishing malignant mesotheliomas from benign mesothelial proliferations.
Chang S; Oh MH; Ji SY; Han J; Kim TJ; Eom M; Kwon KY; Ha SY; Choi YD; Lee CH; Lee Y; Jung SH
Pathol Int; 2014 Dec; 64(12):607-12. PubMed ID: 25376377
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of membranous staining of mesothelioma.
King JA; Tucker JA
Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
[TBL] [Abstract][Full Text] [Related]
16. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis.
Cury PM; Butcher DN; Corrin B; Nicholson AG
J Pathol; 1999 Oct; 189(2):251-7. PubMed ID: 10547583
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin.
Duggan MA; Masters CB; Alexander F
Acta Cytol; 1987; 31(6):807-14. PubMed ID: 2447718
[TBL] [Abstract][Full Text] [Related]
18. Localized fibrous tumors of the pleura: correlation of histopathological, immunohistochemical and ultrastructural features.
Steinetz C; Clarke R; Jacobs GH; Abdul-Karim FW; Petrelli M; Tomashefski JF
Pathol Res Pract; 1990 Jun; 186(3):344-57. PubMed ID: 1696007
[TBL] [Abstract][Full Text] [Related]
19. Pleural mesothelioma of connective tissue type, localized fibrous tumour of the pleura, and reactive submesothelial hyperplasia. An immunohistochemical comparison.
Al-Izzi M; Thurlow NP; Corrin B
J Pathol; 1989 May; 158(1):41-4. PubMed ID: 2754539
[TBL] [Abstract][Full Text] [Related]
20. The serous membranes in the cat. Electron microscopic observations.
Michailova KN
Ann Anat; 1996 Oct; 178(5):413-24. PubMed ID: 8931852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
